Detalhe da pesquisa
1.
Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases.
J Neurooncol
; 164(2): 321-330, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648933
2.
Outcomes of first-line anti-PD-L1 blockades combined with brain radiotherapy for extensive-stage small-cell lung cancer with brain metastasis.
J Neurooncol
; 159(3): 685-693, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976547
3.
Tuftsin-tailored fusion protein inhibits the growth of circulating gastric tumor cells associated with macrophage phagocytosis.
Biochem Biophys Rep
; 34: 101443, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36875797
4.
Modification and application of sports rehabilitation materials based on conjugated materials.
Front Chem
; 11: 1294152, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38075494
5.
Multimodality MRI Radiomics Based on Machine Learning for Identifying True Tumor Recurrence and Treatment-Related Effects in Patients with Postoperative Glioma.
Neurol Ther
; 12(5): 1729-1743, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488335
6.
An interpretable machine learning model for stroke recurrence in patients with symptomatic intracranial atherosclerotic arterial stenosis.
Front Neurosci
; 17: 1323270, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260008
7.
Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis.
Front Med
; 16(4): 610-617, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290596
8.
Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy.
Cancer Lett
; 541: 215719, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35597478
9.
Comprehensive Analysis and Validation of Competing Endogenous RNA Network and Tumor-infiltrating Immune Cells in Lung Adenocarcinoma.
Comb Chem High Throughput Screen
; 25(13): 2240-2254, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35331104
10.
Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor.
Immunotherapy
; 14(14): 1097-1107, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093721
11.
Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC.
Cancer Med
; 10(1): 3-14, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230935
12.
Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung Cancer.
Front Oncol
; 11: 603271, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079751
13.
Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
Onco Targets Ther
; 14: 1623-1631, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688209
14.
The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors.
Front Immunol
; 12: 670391, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34367136
15.
Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study.
Radiat Oncol
; 16(1): 233, 2021 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865626
16.
The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients.
Cancer Biol Med
; 17(3): 599-611, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32944393
17.
Clinical Outcomes for PD-1 Inhibitor Plus Chemotherapy as Second-Line or Later Therapy Compared to PD-1/PD-L1 Inhibitor Alone in Advanced Non-small-cell Lung Cancer.
Front Oncol
; 10: 556275, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33102221
18.
MTAP-deficiency could predict better treatment response in advanced lung adenocarcinoma patients initially treated with pemetrexed-platinum chemotherapy and bevacizumab.
Sci Rep
; 10(1): 843, 2020 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31965001
19.
Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer.
J Hematol Oncol
; 12(1): 67, 2019 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253167
20.
Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases.
Cancer Manag Res
; 11: 10083-10092, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819641